维普中文期刊产品整合服务
71篇 您的检索式:作者名="Trefzer"
    题名 作者 年代 出处 被引量
1Results of a phase Ⅲ, randomized, placebo-controlled study of so- rafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage Ⅲ or stage Ⅳ melanoma 显示文摘Hauschild A Agarwala SS Trefzer U 2009J Clin Oncol2009,27,17:1
2Cloning of an avilamycinbiosynthetic gene cluster from Streptomyces viridoehrongenes Tu57 显示文摘Gaisser S Trefzer A Stockert S 1997Journal of Bacteriology1997,179,20:1
3BREAK-2:a Phase IIA trial of the selective BRAF kinase inhibitor GSK2118436 in patients with BRAF mutation-positive (V600E/K) metastatic melanoma显示文摘TREFZER U MINOR D RIBAS A 0,,:1
4Biosynthesis of the orthosomycin antibiotic avilamyein A:deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tti57 and production of new antibiotics 显示文摘Weitnauer G Muhlenweg A Trefzer A 2001Chemistry&Biology2001,8,6:1
5Biocatalytic Conversion of Avermectin to 4'-Oxo-avermectin: Improvement of Cytochrome P450 Monooxygenase Specificity by Directed Evolution显示文摘TREFZER A JUNGMANN V MOLNAR I 2007Applied and Environmental Microbiology2007,73,13:1
6Rationally designed glycosylated premithramycins: hybrid aromatic polyketides using genes from three different biosynthetic pathways 显示文摘Trefzer A Blanco G Remsing L 2002J Am Chem Soc2002,124,:1
7Proteome serological determination of tumor-associated antigens in melanoma显示文摘Forgber M Trefzer U Sterry W 2009PLoS One2009,,4:1
8Results of a phase In, randomized, placebo-controUed study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma 显示文摘Hauschild A Agarwala SS Trefzer U 2009J Clin Oncol2009,27,17:1
9Hybrid-cell vaccines for cancer immune therapy显示文摘Trefzer U Walden P 2003Mol Biotech2003,25,1:1
10Resuhs of a phase Ⅲ, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage Ⅲ or stage Ⅳ melanoma 显示文摘Hauschild A Agarwala SS Trefzer U 2009J Clin Oncol2009,27,17:1
11Results of a phase Ⅲ, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paelitaxel as second-line treatment in patients with unresectable stagem or stage Ⅳ melanoma 显示文摘Hauschild A Agarwala SS Trefzer U 2009J Clin Oncol2009,27,17:1
12Results of a phase In, randomized, placebo-controUed study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma 显示文摘Hauschild A Agarwala SS Trefzer U 2009J Clin Oncol2009,27,17:1
13Hybrid-cell vaccines for cancer immune therapy显示文摘Trefzer U Walden P 2003Mol Biotechnol2003,25,1:1
14A phase II study assessing overall intracranial response rate ( OIRR) to dabrafenib (GSK2118436) in patients (pts) with BRAF V600E/k mutation-positive melanoma with brain metastases显示文摘KIRKWOODJM GEORGINA VL TREFZER UWE etal 2012J Clin Oncol2012,,:1
15Cloning of an Avilamycin Biosynthetic Gene Cluster from Streptomy- ces viridochromogenes Tu57 显示文摘GAISSER S TREFZER A STOCKERT S 1997Journal of Bacteriology1997,179,20:1
16Different responses of circulating endothelial progenitor cells and VEGF-plasma concentrations to low-dose metronomic and conventional chemotherapy 显示文摘Trefzer T Stoelting S Lemke A 2007Journal of Clinical Oncology2007,25,14:1
17Hybrid cell vaccination for cancer immune therapyfirst clinical trial with metastatic melanoma 显示文摘Trefzer U Weingart G Chen Y W 2000Int J Cancer2000,85,:1
18Results of a multieenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma 显示文摘Eisen T Trefzer U Hamilton A 2010Cancer2010,116,1:1
19Biosynthesis of the orthosomycin antibiotic avilamycin Adeductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces virdochromogenes Tu57 and production of new antibiotics 显示文摘Weitnauer G Mtihlenweg A Trefzer A 2001Chem Bio2001,8,6:1
20Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage Ⅲ and IV patients显示文摘Trefzer U Herberth G Wohlan K 2004Int J Cancer2004,110,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费